Jaime Merchan, MD, discusses the efficacy results observed in the LITESPARK-013 trial of belzutifan in patients with advanced clear cell renal cell carcinoma.

In an interview with Targeted Oncology, Jaime Merchan, MD, delved into data from the LITESPARK-013 trial evaluating ...

Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.

Analysis of genome-wide spatial transcriptomics data reveals cell-type specific subcellular RNA localization, and a subset of genes show significantly high correlation between spatial patterning and 3 ...

Scientists have uncovered a new role for a cell's own RNA in fending off attacks by RNA viruses. Some of the cell's RNA ...

Long before home video cameras became popular, Austin’s Highland Mall offered shoppers a way to record holiday greetings that ...

Two lawmakers from California have asked the U.S. Department of Justice to investigate a violent incident at Men’s Central ...

Study analyzed global patterns and trends in ovarian cancer incidence from 1988 to 2017, highlighting variations by ...

It hasn’t achieved commercial success, but there is still plenty of development happening; analog IMC is getting a second ...

Many toys that will be opened by little ones during the holidays will need batteries to operate. But those batteries pose a ...

James Martin, celebrated chef and familiar face on This Morning, has bravely opened up about his battle with cancer. The ...